Skip to content
Screener

Viatris VTRS Total Revenue

Total Revenue at other companies

Pfizer logo
PfizerPFE
$15.03B+2.6%
McKesson logo
McKessonMCK
$105.38B+7.7%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$266.04M+25.9%
Cencora logo
CencoraCOR
$84.75B+5.1%
AMP
Amphastar PharmaceuticalsAMPH
$183.9M+5.4%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$13.82M+38.1%

Segments

By product

See full
Brands$2.42B+5.9%
Generics$1.33B+3.3%
Lipitor$452.2M+16.6%
Norvasc$200.2M+9.6%
EpiPen® Auto-Injectors$129.2M-5.6%
Lyrica ®$120.6M-5.9%

By segment

See full
Developed Markets Segment$2.2B+3.4%
Greater China$713.8M+21.2%
Emerging Markets Segment$543.8M-2.4%
Japan, Australia and New Zealand Segment$296.2M-3.4%

Other financials

Income statement

See full
Gross profit$1.5B+9.3%
Operating income$6.3M-97.3%
Net income-$118.8M-2,483%
EPS (diluted)-$0.10

Balance sheet

See full
Cash & equivalents$890.0M+56.7%
Total debt$13.6B-7.7%
Total equity$14.3B-8.4%
Total assets$35.0B-8.8%

Cash flow

See full
Operating cash flow$381.8M+73.8%
CapEx$52.8M-0.2%
Free cash flow$329.0M+97.2%

Valuation

See full
Market cap$19.35B+59.3%
Enterprise value$32.09B+21.8%
P/S1.3×+0.5×

Profitability

See full
Gross margin34.8%-1.8pp
Operating margin-0.6%
Net margin-2.8%-1.3pp
FCF margin13.3%+0.9pp

Returns & leverage

See full
Return on equity-2.8%-1.3pp
Debt / equity0.0×
Current ratio1.6×+0.2×

Where this comes from

Reported directly by Viatris in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The source filing: Viatris’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:04 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001792044-26-000041
Line itemThree Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Revenues:
Net sales$3,745.9$3,569.0$7,255.6$6,812.2
Other revenues10.913.118.224.2
Total revenues3,756.83,582.17,273.86,836.4
Cost of sales2,300.32,249.24,660.14,342.3
Gross profit1,456.51,332.92,613.72,494.1
Operating expenses:
Research and development248.3218.8496.9440.8

ITEM 6. [Exhibits](#i61e5533529bd4b8b8b580f5cad6a41ec_190) [74](#i61e5533529bd4b8b8b580f5cad6a41ec_190)

FAQ

What is Viatris's total revenue?
Viatris (VTRS) reported total revenue of $3.76B in Q2 2026.
How has Viatris's total revenue changed year-over-year?
Viatris's total revenue increased by 4.9% year-over-year, from $3.58B to $3.76B.
What is the long-term trend for Viatris's total revenue?
Over 4 years (2021 to 2025), Viatris's total revenue has grown at a -5.4% compound annual growth rate (CAGR), from $17.89B to $14.3B.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Viatris's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude